glp-1 gip The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Effects of Dual GLP-1/GIP
Description
This broader platform strategy may create additional long-term optionality and commercial flexibility as the obesity treatment market continues evolving
This can also increase the fermentation of food by gut bacteria because it stays in the stomach longer
doi: 10.4161/isl.2.3.11396
Incapsula incident ID: 926000060368981057-354634663712391598
23872394, May 2014, doi: 10.2174/13816128113199990474
